SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Regenerxbio announced the first patient dosed in the NAAVIGATE trial and received a $100 million milestone payment from AbbVie. This milestone highlights progress in potential one-…
Larimar Therapeutics has submitted the first module of its rolling BLA to the FDA seeking accelerated approval for nomlabofusp. This submission supports the company's goal for mark…
Viridian Therapeutics announced the FDA approval and immediate launch of Lumvoa for thyroid eye disease. This makes Lumvoa the first approved treatment for both active and chronic …
Matinas BioPharma received notice of non-compliance with NYSE American listing standards due to falling below stockholders' equity requirements. The exchange accepted the company's…
Upexi, Inc. has been added to the Russell Microcap Index effective Monday. The inclusion broadens visibility among institutional investors and index funds.
HP Inc. filed an exhibit containing its amended and restated bylaws, which outline specific procedures for shareholder meetings and nominations. This update primarily defines the c…
Summit Group CPAs, P.C. confirmed agreement with statements in the company's recent filing. This routine submission establishes compliance with executive compensation reporting sta…
Ernst & Young authorized the use of their audit report within Stryker's current filing to support the financial statements section. This procedural move facilitates the incorporati…
The FDA issued a proposed rule to identify illegal foreign tobacco products and protect public health by targeting youth-appealing e-cigarettes.
ProAssurance Corporation filed an amended certificate of incorporation, a corporate governance update, with the SEC. This regulatory disclosure defines the company's governance fra…
The FDA accepted the resubmission of the RP1 Biologics License Application for advanced melanoma, with a decision expected by August 2026. This regulatory milestone signals signifi…
CBIZ CPAs P.C. has confirmed agreement with statements made by XTI Aerospace in their recent Form 8-K. This response ensures XTI maintains compliance with the SEC's reporting requi…
Protalix BioTherapeutics filed an 8-K to amend and restate its 2006 Stock Incentive Plan, effective June 25, 2026, to provide updated rewards for employees and directors.
General Electric filed an amendment to its bylaws (Exhibit 3.1). This regulatory update outlines changes to board composition, director elections, and meeting protocols.
The Federal Reserve Board has issued an enforcement action against an employee of Bank of Eufaula and S N B Bancshares, Inc. Details regarding the specific violation were not discl…
The Federal Reserve Board terminated the enforcement action against Jiko Group, Inc. This concludes the regulatory oversight previously focused on the firm.
The Federal Home Loan Bank of New York filed an exhibit detailing its outstanding fixed-rate debt obligations. The disclosure specifically outlines call dates and interest rates fo…
Karbon-X's Senegal mangrove project achieved Verra registration, making it the second globally approved project under the VM0033 methodology. This milestone enhances the company's …
Clearwater Analytics filed a second amended and restated certificate of incorporation with the SEC, revising the authorized number of shares.
Jaguar Health and Napo have agreed to manage third-party inventory until Woodward obtains an Ohio license. This administrative amendment ensures continued product storage and sales…